A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.

Ther Adv Chronic Dis · 2022 · PMC9340330 · PMID 35924008

Europe PMC DOI

hedged sentences

0.0360

closest p · 0.7× alpha

0.0360

boldest claim

The sentences

showed a trendp = 0.036actually significant

The patients in the experimental group also showed a trend of decreasing TBil levels when compared with patients in the control group ( p = 0.036).

also in 53,322 other papers

a decreasing trendno p-value reported

There was a decreasing trend in the IgM and IgA levels in the experimental group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.